StockData
Lipella Pharmaceuticals Inc. logo

Lipella Pharmaceuticals Inc. (LIPO) income statement

LIPOOTCPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q3 năm tài chính 2025, quý kết thúc ngày Sep 30, 2025Last filing: 10-Q on Nov 14, 2025Score 6/30
$0.00+0.00 (0.00%)

Close on Oct 19, 2026Market cap $2.27KP/E –Yield –

Lipella Pharmaceuticals Inc. income statement

Ratios

Latest available, balances at Sep 30, 2025

Profitability, TTM

Gross margin
–
Operating margin
-1387.9%
Net margin
-1367.4%
Return on equity, FY2024
-198.1%

Financial strength

Current ratio
3.24
Debt to equity
–
Debt to assets
–
Cash to current liabilities
288.9%

Valuation

P/E ratio
–
Price to sales
0.01
Price to book
0.00
Dividend yield
–

See a number that looks wrong?